Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Veracyte Inc., 3 years.
Veracyte Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Veracyte Inc. | Grant or award | +5,272 | — | — |
| Nov 25, 2025 | Veracyte Inc. | Open-market sale | −1,106 | $50.25 | $55,577 |
| Nov 5, 2025 | Veracyte Inc. | Option exercise | +10,000 | $5.28 | $52,800 |
| Nov 5, 2025 | Veracyte Inc. | Option exercise | +10,000 | $7.94 | $79,400 |
| Nov 5, 2025 | Veracyte Inc. | Option exercise | +10,000 | $7.60 | $76,000 |
| Nov 5, 2025 | Veracyte Inc. | Open-market sale | −408 | $41.74 | $17,030 |
| Nov 5, 2025 | Veracyte Inc. | Open-market sale | −1,126 | $43.03 | $48,452 |
| Nov 5, 2025 | Veracyte Inc. | Open-market sale | −10,837 | $43.80 | $474,661 |
| Nov 5, 2025 | Veracyte Inc. | Open-market sale | −5,872 | $45.07 | $264,651 |
| Nov 5, 2025 | Veracyte Inc. | Open-market sale | −24,296 | $45.73 | $1,111,056 |
| Nov 5, 2025 | Veracyte Inc. | Open-market sale | −657 | $46.38 | $30,472 |
| Jun 18, 2025 | Veracyte Inc. | Grant or award | +9,321 | — | — |
| Sep 19, 2024 | Veracyte Inc. | Open-market sale | −5,173 | $35.23 | $182,245 |
| Aug 13, 2024 | Veracyte Inc. | Option exercise | +8,486 | $10.41 | $88,339 |
| Aug 13, 2024 | Veracyte Inc. | Open-market sale | −2,931 | $31.19 | $91,418 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.